The regulation of food intake by the gut-brain axis: implications for obesity (Q38019805)

27 August 2017

The regulation of food intake by the gut-brain axis: implications for obesity (English)

1 reference

27 August 2017

0 references

S S Hussain

1

1 reference

27 August 2017

S R Bloom

series ordinal

2

1 reference

27 August 2017

language of work or name

English

0 references

publication date

19 June 2012

1 reference

International Journal of Obesity

27 August 2017

1 reference

27 August 2017

37

1 reference

27 August 2017

5

1 reference

27 August 2017

625-633

1 reference

https://scigraph.springernature.com/pub.10.1038/ijo.2012.93

27 August 2017

0 references

cites work

Set points, settling points and some alternative models: theoretical options to understand how genes and environments combine to regulate body adiposity

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Central nervous system control of food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Homeostatic and non-homeostatic pathways involved in the control of food intake and energy balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

KO's and organisation of peptidergic feeding behavior mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Central nervous system regulation of food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

The pharmacological treatment and management of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Control of energy homeostasis by insulin and leptin: targeting the arcuate nucleus and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Entry of peroxidase into neurons of the central and peripheral nervous systems from extracerebral and cerebral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

A second look at the barriers of the medial basal hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Interacting appetite-regulating pathways in the hypothalamic regulation of body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Formation of projection pathways from the arcuate nucleus of the hypothalamus to hypothalamic regions implicated in the neural control of feeding behavior in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

A role for melanin-concentrating hormone in the central regulation of feeding behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Melanin-concentrating hormone acutely stimulates feeding, but chronic administration has no effect on body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Leptin directly activates SF1 neurons in the VMH, and this action by leptin is required for normal body-weight homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Hypothalamic sensing of fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Sensing the fuels: glucose and lipid signaling in the CNS controlling energy homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Metabolic sensing and the brain: who, what, where, and how?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

The neuroanatomical axis for control of energy balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Hypothalamic-brainstem circuits controlling eating

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Brain-derived neurotrophic factor (BDNF) and food intake regulation: a minireview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Gastrointestinal hormones regulating appetite

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

The role of gastrointestinal vagal afferents in the control of food intake: current prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

The area postrema: a brain monitor and integrator of systemic autonomic state

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Ascending projections from the solitary tract nucleus to the hypothalamus. A Phaseolus vulgaris lectin tracing study in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Descending pathways from hypothalamus to dorsal motor vagus and ambiguus nuclei in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

The role of the hypothalamus and dorsal vagal complex in gastrointestinal function and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Imaging obesity: fMRI, food reward, and feeding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

The gut hormones PYY 3-36 and GLP-1 7-36 amide reduce food intake and modulate brain activity in appetite centers in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Circulating glucose levels modulate neural control of desire for high-calorie foods in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Altered hypothalamic function in diet-induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Gut hormones and the regulation of energy homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Brain mechanisms underlying flavour and appetite

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Brainstem integrative function in the central nervous system control of food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

The cholecystokinin-A receptor mediates inhibition of food intake yet is not essential for the maintenance of body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Ghrelin: structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Ghrelin is a growth-hormone-releasing acylated peptide from stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Ghrelin and appetite control in humans--potential application in the treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Post-prandial decrease of circulating human ghrelin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Ghrelin enhances appetite and increases food intake in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Ghrelin causes hyperphagia and obesity in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Ghrelin in the regulation of body weight and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Acute central ghrelin and GH secretagogues induce feeding and activate brain appetite centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Ghrelin mediates stress-induced food-reward behavior in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Circulating ghrelin levels are decreased in human obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

The hyperphagic effect of ghrelin is inhibited in mice by a diet high in fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Human distribution and release of a putative new gut hormone, peptide YY

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Inhibition of food intake in obese subjects by peptide YY3-36

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Critical role for peptide YY in protein-mediated satiation and body-weight regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Changes in gut hormones after bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Diet and gastrointestinal bypass-induced weight loss: the roles of ghrelin and peptide YY.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

PYY(3-36) reduces food intake and body weight and improves insulin sensitivity in rodent models of diet-induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Effect of peptide YY3-36 on food intake in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Gut hormone PYY(3-36) physiologically inhibits food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

A role for pancreatic polypeptide in the regulation of gastric emptying and short-term metabolic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Mouse pancreatic polypeptide modulates food intake, while not influencing anxiety in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Pancreatic polypeptide reduces appetite and food intake in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Peptide YY 3-36 and pancreatic polypeptide differentially regulate hypothalamic neuronal activity in mice in vivo as measured by manganese-enhanced magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Role of prohormone convertases in the tissue-specific processing of proglucagon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic Peptide release

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Glucagon-like peptide-1 7-36: a physiological incretin in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

The biology of incretin hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Differential patterns of neuronal activation in the brainstem and hypothalamus following peripheral injection of GLP-1, oxyntomodulin and lithium chloride in mice detected by manganese-enhanced magnetic resonance imaging (MEMRI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Oxyntomodulin from distal gut. Role in regulation of gastric and pancreatic functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Oxyntomodulin increases energy expenditure in addition to decreasing energy intake in overweight and obese humans: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Differential hypothalamic neuronal activation following peripheral injection of GLP-1 and oxyntomodulin in mice detected by manganese-enhanced magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Peripheral oxyntomodulin reduces food intake and body weight gain in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Relative quantitative analysis of glucagon receptor mRNA in rat tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Pancreatic signals controlling food intake; insulin, glucagon and amylin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

The metabolic actions of glucagon revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Glucagon-like peptide 1/glucagon receptor dual agonism reverses obesity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

A new glucagon and GLP-1 co-agonist eliminates obesity in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Effect of pramlintide on weight in overweight and obese insulin-treated type 2 diabetes patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

The role of neurotensin in physiologic and pathologic processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Anorexigenic hormones leptin, insulin, and alpha-melanocyte-stimulating hormone directly induce neurotensin (NT) gene expression in novel NT-expressing cell models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Impaired anorectic effect of leptin in neurotensin receptor 1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Biological effects of obestatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

The proglucagon-derived peptide, glucagon-like peptide-2, is a neurotransmitter involved in the regulation of food intake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Lifestyle modification for the management of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Dietary adherence and weight loss success among overweight women: results from the A TO Z weight loss study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Synaptotagmin IV determines the linear Ca2+ dependence of vesicle fusion at auditory ribbon synapses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Long term pharmacotherapy for obesity and overweight: updated meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Effect of orlistat on weight regain and cardiovascular risk factors following a very-low-energy diet in abdominally obese patients: a 3-year randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Valvular heart disease associated with fenfluramine-phentermine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Cardiovascular responses to weight management and sibutramine in high-risk subjects: an analysis from the SCOUT trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Neurogenesis in the hypothalamus of adult mice: potential role in energy balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Ciliary neurotrophic factor activates leptin-like pathways and reduces body fat, without cachexia or rebound weight gain, even in leptin-resistant obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Bariatric surgery and reduction in morbidity and mortality: experiences from the SOS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

New drug targets for the treatment of obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

PYY3-36 and oxyntomodulin can be additive in their effect on food intake in overweight and obese humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Effects of PYY1–36 and PYY3–36 on appetite, energy intake, energy expenditure, glucose and fat metabolism in obese and lean subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Proglucagon Processing Profile in Canine L Cells Expressing Endogenous Prohormone Convertase 1/3 and Prohormone Convertase 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Peripheral administration of GLP-2 to humans has no effect on gastric emptying or satiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Rapid development of tolerance to the behavioural actions of cholecystokinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

Mechanism of the development of obesity in animals with hypothalamic lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

7 January 2021

The arcuate nucleus as a conduit for diverse signals relevant to energy homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

7 January 2021

Evidence that the caudal brainstem is a target for the inhibitory effect of leptin on food intake

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

7 January 2021

Leptin is influenced both by predisposition to obesity and diet composition

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

7 January 2021

Cholecystokinin decreases food intake in rats.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

7 January 2021

C-terminal octapeptide of cholecystokinin decreases food intake in man.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

7 January 2021

C-fos protein expression in the nucleus of the solitary tract correlates with cholecystokinin dose injected and food intake in rats

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

7 January 2021

Brain regions where cholecystokinin suppresses feeding in rats

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

7 January 2021

Infusion of cholecystokinin between meals into free-feeding rats fails to prolong the intermeal interval

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

7 January 2021

Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

7 January 2021

Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

7 January 2021

Glucagon-like peptide analogues for type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

7 January 2021

Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

7 January 2021

Distribution of glucagonlike peptide I (GLP-I), glucagon, and glicentin in the rat brain: an immunocytochemical study

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

7 January 2021

Effect of glucagon on food intake and body weight in man.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

7 January 2021

Insulin and glucagon as determinants of body weight set point and microregulation in rats

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

7 January 2021

Stimulation of feeding in rats by intraperitoneal injection of antibodies to glucagon

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

7 January 2021

Proglucagon processing profile in canine L cells expressing endogenous prohormone convertase 1/3 and prohormone convertase 2

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

7 January 2021

Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

7 January 2021

Long-term persistence with orlistat and sibutramine in a population-based cohort

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

7 January 2021

Recombinant variant of ciliary neurotrophic factor for weight loss in obese adults: a randomized, dose-ranging study

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2012.93

7 January 2021

Identifiers

DOI

10.1038/IJO.2012.93

1 reference

Dimensions Publication ID

27 August 2017

0 references

1 reference